Condition

Biopsy Proven Acute Rejection

ClinicalTrials.gov condition label

Clinical trials1

Recruiting0

Common interventions2

Lead sponsors shown1

Clinical trials

1 shown

Silymarin's Advantage on Graft EffectivenessNCT06801886 · 2020-01-07

ENROLLING_BY_INVITATION

Common interventions

Placebo SupplementationOTHER1Silymarine supplementationDRUG1

Leading sponsors

University Hospital, Martin1

Trial status mix

ENROLLING_BY_INVITATION1

Phase mix

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.